This opportunity is no longer accepting applications.
grant HT942524ALSRPTDA

DOD Amyotrophic Lateral Sclerosis, Therapeutic Development Award

The FY24 ALSRP Therapeutic Development Award funds research for therapies targeting ALS, from preclinical validation to FDA IND-enabling studies. Projects should be empirical and product-focused, starting with lead compounds and proof-of-concept data in ALS models. Applicants are encouraged to collaborate with ALS experts. The grant supports the development of predictive biomarkers alongside t…

The FY24 ALSRP Therapeutic Development Award supports research ranging from preclinical validation of therapeutic leads through Food and Drug Administration (FDA) Investigational New Drug (IND)-enabling studies. The proposed studies are expected to be empirical in nature and product-driven. Appl…

Funding Source

Agency: Dept. of the Army -- USAMRAA
Program: SBIR

Awards & funding

Total Funding: $9.6M
Total Awards Given 4

Dates

Opportunity Released: March 25, 2024
Open for Submission: March 25, 2024
Submission Deadline: July 10, 2024
Application Window Closes: July 10, 2024

Documents

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.